PRLAX
Price
$20.14
Change
+$0.03 (+0.15%)
Updated
Jun 6 closing price
Net Assets
370.07M
SLAPX
Price
$29.03
Change
+$0.05 (+0.17%)
Updated
Jun 6 closing price
Net Assets
277.42M
Interact to see
Advertisement

PRLAX vs SLAPX

Header iconPRLAX vs SLAPX Comparison
Open Charts PRLAX vs SLAPXBanner chart's image
T. Rowe Price Latin America
Price$20.14
Change+$0.03 (+0.15%)
VolumeN/A
Net Assets370.07M
DWS Latin America Equity C
Price$29.03
Change+$0.05 (+0.17%)
VolumeN/A
Net Assets277.42M
PRLAX vs SLAPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PRLAX vs. SLAPX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRLAX is a Buy and SLAPX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRLAX has more cash in the bank: 370M vs. SLAPX (277M). SLAPX pays higher dividends than PRLAX: SLAPX (3.36) vs PRLAX (2.93). PRLAX was incepted earlier than SLAPX: PRLAX (31 years) vs SLAPX (24 years). SLAPX (2.35) is less costly to investors than PRLAX (1.46). SLAPX is a more actively managed with annual turnover of: 101.00 vs. PRLAX (23.20). SLAPX has a lower initial minimum investment than PRLAX: SLAPX (1000) vs PRLAX (2500). SLAPX annual gain was more profitable for investors over the last year : 7.13 vs. PRLAX (3.62). SLAPX return over 5 years is better than : 39.88 vs. PRLAX (20.18).
PRLAXSLAPXPRLAX / SLAPX
Total Expense Ratio1.462.1867%
Annual Report Gross Expense Ratio1.462.3562%
Fund Existence31 years24 years-
Gain YTD23.90629.89780%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets370M277M134%
Annual Yield % from dividends2.933.3687%
Returns for 1 year3.627.1351%
Returns for 3 years17.6316.45107%
Returns for 5 years20.1839.8851%
Returns for 10 years16.4972.4523%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WSTCX24.480.14
+0.58%
Macquarie Science and Technology C
MUETX35.82N/A
N/A
MFS Blended Research Core Equity R3
WLCVX21.50N/A
N/A
Wilshire Large Company Value Instl
SMIPX13.32N/A
N/A
Saratoga Mid Capitalization I
MNBIX19.86N/A
N/A
Manning & Napier Pro-Blend Extnd Term I